The FDA sent a warning letter this month to Novo Nordisk, alleging the drugmaker failed to report, in a timely manner, potential side effects in patients who took its popular medications containing semiglutide.
FDA sends warning letter to maker of Ozempic, Wegovy over unreported potential GLP-1 side effects
Related Posts
-
Trump calls for bipartisan healing after another incident. But will it last?
The president suggested that his personal politics had made him a repeated target
-
Four injured in shooting at Arkansas State University
A woman was shot in the leg on the campus of Arkansas State University early…
-
Ankeny Innovation Hub progress continues with major summer construction ahead
Major progress is being made on Ankeny’s new Innovation Hub, with roadwork, field demolition, and…
-
Iowa State University to launch online and accelerated nursing programs
Iowa State University is introducing two new nursing programs, including an online master’s degree and…
Leave a Reply